Jaguar Health has completed the conversion of a special preferred-stock dividend into common shares, increasing the number of shares outstanding. The dividend was distributed on October 15, and the preferred shares automatically converted on November 2.
- Dividend and conversion: Holders of each eligible common share received one share of Series R preferred stock. The distribution also covered certain warrants and pre-funded warrants, representing rights tied to as many as 142,535 common shares. Each outstanding preferred share converted automatically into five common shares on November 2.
- Share count after conversion: Jaguar had 13,345,986 common shares issued and outstanding immediately after the conversion.
- Warrant-related shares: Holders of the eligible warrants may receive up to 69,823 common shares upon exercising them. That figure includes the warrant shares and shares associated with the preferred-stock dividends.
The conversion put common shares in place of the preferred shares; the warrant-related shares remain contingent on exercise. The disclosed post-conversion share count does not include those potential warrant shares.